文献速递心脑血管急症重症综合管理与镇静镇痛

梗死部位对溶栓治疗的ST段抬高型心肌梗死临床终点的影响

Effect of infarct site on the clinical endpoints of thrombolytic-treated ST-elevation myocardial infarction.
PubMed 文献 · Am J Emerg Med · 2019-04-12
一句话结论在溶栓治疗的STEMI患者中,右冠状动脉分布组较左前降支和左回旋支分布组的院内全因死亡率、心源性休克发生率更低、住院时间更短。

本研究从2014年全国再入院数据库中提取溶栓治疗的STEMI患者共1231例,按冠状动脉分布分为左前降支组431例、左回旋支组124例和右冠状动脉组676例。主要终点为院内全因死亡率、住院时间、心源性休克和机械并发症。与左前降支和左回旋支分布相比,右冠状动脉分布组死亡率更低(3.6% vs 6.5%和5.7%,p=0.02)、心源性休克更少(7.7% vs 12.3%和12.1%,p=0.01)、住院时间更短(3.6天 vs 4.5天和3.9天,p<0.01)。机械并发症在各冠状动脉分布间无显著差异(p=0.17)。

要点

  • 溶栓治疗的STEMI中,右冠状动脉分布组院内全因死亡率为3.6%,低于左前降支组的6.5%和左回旋支组的5.7%(p=0.02)。
  • 右冠状动脉分布组心源性休克发生率为7.7%,低于左前降支组的12.3%和左回旋支组的12.1%(p=0.01)。
  • 右冠状动脉分布组住院时间最短(3.6天),左回旋支组为3.9天,左前降支组为4.5天(p<0.01)。
  • 机械并发症在各冠状动脉分布间无显著差异(左前降支2.3%、左回旋支3.2%、右冠状动脉1.2%,p=0.17)。

适用人群与场景

  • 2014年全国再入院数据库中主要诊断为溶栓治疗的ST段抬高型心肌梗死患者,共1231例,平均年龄61.5岁,女性占26.5%。

研究设计与关键结果

  • 研究为基于2014年全国再入院数据库的回顾性分析,共纳入1231例溶栓治疗的STEMI患者,按冠状动脉分布分为左前降支组431例、左回旋支组124例和右冠状动脉组676例。
  • 院内全因死亡率:左前降支组6.5%、左回旋支组5.7%、右冠状动脉组3.6%(p=0.02)。
  • 心源性休克发生率:左前降支组12.3%、左回旋支组12.1%、右冠状动脉组7.7%(p=0.01)。
  • 住院时间:左前降支组4.5天、左回旋支组3.9天、右冠状动脉组3.6天(p<0.01)。
  • 机械并发症发生率:左前降支组2.3%、左回旋支组3.2%、右冠状动脉组1.2%(p=0.17),无显著差异。

证据类型、等级与局限

  • 证据类型:基于全国再入院数据库的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 本研究提示溶栓治疗的STEMI患者中,右冠状动脉分布者的院内死亡、心源性休克和住院时间结局优于左前降支和左回旋支分布者,机械并发症无差异。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Some studies suggest better outcomes after the use of thrombolytics in inferior ST-elevation myocardial infarction (STEMI) compared to other locations. The goal of this study is to compare the clinical endpoints of thrombolytic-treated STEMI based on coronary artery distribution.

METHODS: The study population was extracted from the 2014 Nationwide Readmissions Data using the International Classification of Diseases, Ninth Revision, Clinical Modifications codes for STEMI, thrombolytic infusion, and complications of STEMI. Primary study endpoints included in-hospital all-cause mortality, length of hospital stay (LOS), cardiogenic shock, and mechanical complications of STEMI.

RESULTS: A principal diagnosis of thrombolytic-treated STEMI was identified for in 1231 patients (mean age 61.5 years; 26.5% female). Four hundred and thirty-one STEMIs occurred in the left anterior descending (LAD) artery distribution, 124 in the left circumflex (LCX) artery distribution, and 676 in the right coronary artery (RCA) distribution. In comparison to the LAD and LCX distributions, thrombolytic-treated STEMIs in the RCA distribution were associated with lower mortality (6.5% with LAD, 5.7% with LCX, and 3.6% with RCA; p = 0.02), fewer cardiogenic shock (12.3% with LAD, 12.1% with LCX, and 7.7% with RCA; p = 0.01), and shorter LOS (4.5 days with LAD, 3.9 with LCX, and 3.6 days with RCA; p < 0.01). Mechanical complications showed no significant difference based on coronary distribution (2.3% with LAD, 3.2% with LCX, and 1.2% with RCA; p = 0.17).

CONCLUSIONS: Thrombolytic-treated STEMIs in the RCA distribution were associated with lower in-hospital all-cause mortality, cardiogenic shock, and shorter LOS. Mechanical complications were not different based on coronary distribution.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Gifft K, Dohrmann M, Eniezat M, et al. Effect of infarct site on the clinical endpoints of thrombolytic-treated ST-elevation myocardial infarction. Am J Emerg Med. 2019. PMID: 31005391. doi:10.1016/j.ajem.2019.04.026

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。